Xontogeny portfolio

Xontogeny (Accelerator) is known to hold 28 companies, 20 of them startups. 6 of them are hiring now, with 37 open roles. Most of them work in Rare Disease Therapeutics, Cell & Gene Therapy, Venture Capital.

Source: Alion Accelerator Oct 2, 2026
Investments
28
20 of them startups
Hiring now
6
37 open roles
Exits
3

Companies Xontogeny has invested in

Adaptilens Ophthalmology & Eye Clinics · United States Series A $17.5M · 2 yr ago portfolio pageSep 25
Peroxitech Inc. Series A $25M · 3 yr ago portfolio pageSep 25
Tellus Therapeutics Cell & Gene Therapy · United States Venture round $16M · 3 yr ago portfolio pageSep 25
Surf Bio Seed $16M · 4 yr ago portfolio pageSep 25
VivoSense Clinical Trial Services (CRO) Venture round $25M · 4 yr ago 1 role portfolio pageSep 25
Aalphabio Synthetic Biology · United States Venture round $20.3M · 5 yr ago 2 roles portfolio pageSep 25
Forge Biologics CRO & CDMO Services · United States Series B $120M · 5 yr ago 15 roles portfolio pageSep 25
Lianbio iGaming & Gambling Venture round $3M · 5 yr ago portfolio pageSep 25
CereVasc eShunt® Device | Under Development for Hydrocephalus United States Venture round $11.1M · 6 yr ago portfolio pageSep 25
Abbvie Venture round $60.3M · 7 yr ago portfolio pageSep 25
Galvanize Therapeutics® Inc Property & Casualty Insurance 8 roles portfolio pageSep 25
Avalynpharma Prescription Drugs · United States 4 roles portfolio pageSep 25
Apogee Therapeutics Biologics & Biosimilars · United States portfolio pageSep 25
NephroDI Therapeutics Rare Disease Therapeutics portfolio pageSep 25
Perceptive Advisors Hedge Funds & Alternative Investments · United States portfolio pageSep 25
Sermonix Pharmaceuticals Women’s Health & Maternity portfolio pageSep 25
Solid_Bio Cell & Gene Therapy portfolio pageSep 25
What to Inc Sports Betting portfolio pageSep 25

Focus

Markets
Rare Disease Therapeutics11%
Cell & Gene Therapy11%
Venture Capital4%
Asset Management & Funds4%
Hedge Funds & Alternative Investments4%
Machine Learning4%
Synthetic Biology4%
Ophthalmology & Eye Clinics4%
Where its companies are
United States29%
Stage of its companies
Venture, series not stated60%
Series A20%
Series B10%
Pre-seed & seed10%

Questions about Xontogeny

How many companies has Xontogeny invested in?

Xontogeny is known to hold 28 companies: 20 startups, and 3 exits so far, read from its own portfolio page and the funding rounds that name it.

Is Xontogeny investing now?

Xontogeny has no round in the press in 12 months and no new company on its portfolio page in 90 days.

What does Xontogeny invest in?

The markets of the companies Xontogeny holds: Rare Disease Therapeutics (11%), Cell & Gene Therapy (11%), Venture Capital (4%), Asset Management & Funds (4%), Hedge Funds & Alternative Investments (4%).

Which Xontogeny portfolio companies are hiring?

6 companies Xontogeny holds are hiring now, with 37 open roles listed on this page.

Who does Xontogeny invest alongside?

The investors that hold the most companies together with Xontogeny: Wellington Management, RA Capital Management.

How this page is made

A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.

Xontogeny portfolio: 28 known companies. Alion, Oct 2, 2026. https://alion.io/company/xontogeny/portfolio

Licence: CC BY-SA 4.0JSON